Mortality hazard and survival after tuberculosis treatment

American Journal of Public Health

Volumn 105, Issue 5, 2015, Pages 930-937

  Miller, Thaddeus L ^a   Wilson, Fernando A ^c   Pang, Jenny W ^d   Beavers, Suzanne ^e   Hoger, Sally ^f   Sharnprapai, Sharon ^g   Pagaoa, Melissa ^e   Katz, Dolly J ^e   Weis, Stephen E ^b  

^a UNT Health Sciences Center   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f TARLETON STATE UNIVERSITY   (United States)

^g MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANCESTRY GROUP; CAUSE OF DEATH; FEMALE; HIV INFECTIONS; HUMAN; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MORTALITY; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVOR; TIME; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONTINENTAL POPULATION GROUPS; FEMALE; HIV INFECTIONS; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; TIME FACTORS; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

EID: 84926642385     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302431     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep. 1989;38(suppl S-3):1-25.
2. Institute of Medicine. Ending Neglect: The Elimination of Tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
3. Federal Tuberculosis Task Force. Federal Tuberculosis Task Force Plan in Response to the Institute of Medicine Report, Ending Neglect: The Elimination of Tuberculosis in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
4. Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Recomm Rep. 1999;48(RR-9):1-13.
5. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2012. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2013.
6. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-355.
7. Hill AN, Becerra JE, Castro KG. Modeling tuberculosis trends in the USA. Epidemiol Infect. 2012;140(10):1862-1872.
8. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555-564.
9. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1-51.
10. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131-138.
11. Vynnycky E, Fine PE. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol. 2000;152(3):247-263.
12. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the U. S. and Canada. Int J Tuberc Lung Dis. 2008;12(11):1235-1254.
13. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146(5):340-354.
14. De Perio MA, Tseval J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med. 2009;169(2):179-187.
15. Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011;15(2):246-250.
16. Freixinet J. Surgical indications for treatment of pulmonary tuberculosis. World J Surg. 1997;21(5):475-479.
17. Sodeman WA, Sodeman TM, eds. Pathologic Physiology: Mechanisms of Disease. 7th ed. Philadelphia, PA: W. B. Saunders; 1985.
18. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest. 1998;113(4):933-943.
19. Pasipanodya JG, McNabb SJN, Hisenrath PE, et al. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010;10:259.
20. Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817-1824.
21. Vecino M, Pasipanodya JG, Slocum P, et al. Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis. J Infect Public Health. 2011;4(5-6):244-252.
22. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment by initial and recurrent pulmonary tuberculosis following treatment Thorax. 2000;55(1):32-38.
23. Pasipanodya JG, Miller TL, Vecino M, et al. Using the St George's Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest. 2007;132(5):1591-1598.
24. Menezes AM, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30(6):1180-1185.
25. Schuneman HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118(3):656-664.
26. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388-393.
27. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: population-based study and a systemic review of the literature. Chest. 2005;127(6):1952-1959.
28. Shaw JET, Pasipanodya JG, Gumbo T. Meningeal tuberculosis: high long-term mortality despite standard therapy. Medicine. 2010;89(3):189-195.
29. Katz D, Albalak R, Wing JS, Combs V; Tuberculosis Epidemiologic Studies Consortium. Setting the agenda: a new model for collaborative tuberculosis epidemiologic research. Tuberculosis (Edinb). 2007;87(1):1-6.
30. Centers for Disease Control and Prevention. Tuberculosis control laws and policies: a handbook for public health and legal practitioners. 2009. Available at: http://www.cdc.gov/tb/programs/TBlawPolicyHandbook.pdf. Accessed December 19, 2011.
31. Centers for Disease Control and Prevention. Report of Verified Case of Tuberculosis (RVCT) Instruction Manual. Atlanta, GA: US Department of Health and Human Services; 2009.
32. Centers for Disease Control and Prevention. Tuberculosis information management system. Available at: http://www.cdc.gov/tb/programs/tims/tims.htm. Accessed January 10, 2012.
33. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2005;54(RR-12):1-81.
34. National Center for Health Statistics, Centers for Disease Control and Prevention. National Death Index matching criteria. Available at: http://www.cdc.gov/nchs/data/ndi/NDICriteria-Front.pdf. Accessed February 1, 2012.
35. National Program of Cancer Registries. Registry Plus Link Plus. Available at: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm. Accessed January 15, 2012.
36. Centers for Disease Control and Prevention. NDI user guide. Available at: http://www.cdc.gov/nchs/data-access/ndi/ndi-user-guide.htm. Accessed July 16, 2012.
37. LexisNexis Risk Solutions. LexisNexis accurint homepage. Available at: http://www.accurint.com/index.html. Accessed August 15, 2012.
38. Centers for Disease Control and Prevention. NCHS National Death Index. Available at: http://www.cdc.gov/nchs/ndi.htm. Accessed June 15, 2012.
39. Centers for Disease Control and Prevention. NCHS National Death Index health research bibliography. Available at: http://www.cdc.gov/nchs/data/ndi/ndi-bibliography-health-research.pdf. Accessed April 19, 2012.
40. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2012.
41. Koek HL, De Bruin A, Gast F, et al. Short- and long-term prognosis after acute myocardial infarction in men versus women. Am J Cardiol. 2006;98(8):993-999.
42. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. Natl Vital Stat Rep. 2010;58(19):1-19.
43. Arias E. United States life tables, 2007. Natl Vital Stat Rep. 2011;59(9):1-60.
44. Billings J. Using administrative data to monitor access, identify disparities, and assess performance of the safety net. In: Billings J, Weinick R, eds. Tools for Monitoring the Health Care Safety Net. Agency for Health Care Research and Quality. Rockville, MD: Agency for Health Care Policy and Research; 2003. AHRQ Pub No. 03-0027.
45. Hermansen SW, Leitzmann MF, and Schatzkin A. The impact on National Death Index ascertainment of limiting submissions to Social Security Administration death master file matches in epidemiologic studies of mortality. Am J Epidemiol. 2009;169(7):901-908.
46. Linas BP, Wong AY, Freedberg KA, Horsburgh CR Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011;184(5):590-601.